Glucocorticoids and Airway Smooth Muscle: A Few More Answers, Still More Questions.
作者信息
Nayak Ajay P
机构信息
1 Center for Translational Medicine and.
2 Jane and Leonard Korman Respiratory Institute Thomas Jefferson University Philadelphia, Pennsylvania.
出版信息
Am J Respir Cell Mol Biol. 2019 Jul;61(1):9-10. doi: 10.1165/rcmb.2019-0089ED.
Abstract
摘要
相似文献
1
Glucocorticoids and Airway Smooth Muscle: A Few More Answers, Still More Questions.糖皮质激素与气道平滑肌：更多解答，仍有更多问题。
Am J Respir Cell Mol Biol. 2019 Jul;61(1):9-10. doi: 10.1165/rcmb.2019-0089ED.
2
Stimulus-dependent glucocorticoid-resistance of GM-CSF production in human cultured airway smooth muscle.人培养气道平滑肌中粒细胞-巨噬细胞集落刺激因子产生的刺激依赖性糖皮质激素抵抗
Br J Pharmacol. 2005 May;145(1):123-31. doi: 10.1038/sj.bjp.0706174.
3
The antimalarial drug artesunate inhibits primary human cultured airway smooth muscle cell proliferation.青蒿琥酯抑制原代人培养气道平滑肌细胞增殖。
Am J Respir Cell Mol Biol. 2014 Feb;50(2):451-8. doi: 10.1165/rcmb.2013-0273OC.
4
The effect of glucocorticoids on proliferation of human cultured airway smooth muscle.糖皮质激素对人培养气道平滑肌增殖的影响。
Br J Pharmacol. 1995 Dec;116(8):3219-26. doi: 10.1111/j.1476-5381.1995.tb15127.x.
5
Glucocorticoid Receptor ChIP-Seq Identifies PLCD1 as a KLF15 Target that Represses Airway Smooth Muscle Hypertrophy.糖皮质激素受体染色质免疫沉淀测序确定PLCD1为抑制气道平滑肌肥大的KLF15靶点。
Am J Respir Cell Mol Biol. 2017 Aug;57(2):226-237. doi: 10.1165/rcmb.2016-0357OC.
6
Glucocorticosteroids and β₂-adrenoceptor agonists synergize to inhibit airway smooth muscle remodeling.糖皮质激素和β₂-肾上腺素能受体激动剂协同抑制气道平滑肌重塑。
J Pharmacol Exp Ther. 2012 Sep;342(3):780-7. doi: 10.1124/jpet.112.195867. Epub 2012 Jun 8.
7
Airway smooth muscle as a target of glucocorticoid action in the treatment of asthma.气道平滑肌作为糖皮质激素治疗哮喘作用的靶点。
Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 3):S201-6. doi: 10.1164/ajrccm.158.supplement_2.13tac190.
8
[The role of dexamethasone on airway wall remodeling].[地塞米松在气道壁重塑中的作用]
Zhonghua Jie He He Hu Xi Za Zhi. 2001 Mar;24(3):152-4.
9
beta2-Adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation.β2肾上腺素能受体激动剂与糖皮质激素一样，通过选择性抑制组蛋白H4乙酰化来抑制嗜酸性粒细胞趋化因子基因转录。
J Immunol. 2005 Jul 1;175(1):478-86. doi: 10.4049/jimmunol.175.1.478.
10
Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade.半胱氨酰白三烯1型受体阻断对变应原诱导的气道重塑的逆转作用
Am J Respir Crit Care Med. 2006 Apr 1;173(7):718-28. doi: 10.1164/rccm.200501-088OC. Epub 2005 Dec 30.
引用本文的文献
1
Drugs Used in the Treatment of Viral Infections for the Prevention of Airway Remodeling in Asthma.用于治疗病毒感染以预防哮喘气道重塑的药物。
Mediators Inflamm. 2025 Jul 24;2025:5526526. doi: 10.1155/mi/5526526. eCollection 2025.
2
The Impact of Corticosteroids on Human Airway Smooth Muscle Contractility and Airway Hyperresponsiveness: A Systematic Review.皮质类固醇对人呼吸道平滑肌收缩性和气道高反应性的影响：系统评价。
Int J Mol Sci. 2022 Dec 4;23(23):15285. doi: 10.3390/ijms232315285.
3
ZDHXB-101 (3',5-Diallyl-2, 4'-dihydroxy-[1,1'-biphen-yl]-3,5'-dicarbaldehyde) protects against airway remodeling and hyperresponsiveness via inhibiting both the activation of the mitogen-activated protein kinase and the signal transducer and activator of transcription-3 signaling pathways.ZDHXB-101（3'，5-二烯丙基-2,4'-二羟基-[1,1'-联苯]-3,5'-二醛）通过抑制丝裂原活化蛋白激酶和信号转导及转录激活因子 3 信号通路的激活，来防止气道重塑和高反应性。
Respir Res. 2020 Jan 13;21(1):22. doi: 10.1186/s12931-020-1281-x.
本文引用的文献
1
Airway Smooth Muscle-Specific Transcriptomic Signatures of Glucocorticoid Exposure.糖皮质激素暴露的气道平滑肌特异性转录组特征。
Am J Respir Cell Mol Biol. 2019 Jul;61(1):110-120. doi: 10.1165/rcmb.2018-0385OC.
2
New targets for resolution of airway remodeling in obstructive lung diseases.阻塞性肺疾病气道重塑消退的新靶点。
F1000Res. 2018 May 30;7. doi: 10.12688/f1000research.14581.1. eCollection 2018.
3
Glucocorticoid Receptor ChIP-Seq Identifies PLCD1 as a KLF15 Target that Represses Airway Smooth Muscle Hypertrophy.糖皮质激素受体染色质免疫沉淀测序确定PLCD1为抑制气道平滑肌肥大的KLF15靶点。
Am J Respir Cell Mol Biol. 2017 Aug;57(2):226-237. doi: 10.1165/rcmb.2016-0357OC.
4
Glucocorticoids and airway smooth muscle: some answers, more questions.糖皮质激素与气道平滑肌：一些答案，更多问题。
Am J Respir Crit Care Med. 2013 May 15;187(10):1040-1. doi: 10.1164/rccm.201303-0530ED.
5
Severe asthma: advances in current management and future therapy.严重哮喘：当前管理和未来治疗的进展。
J Allergy Clin Immunol. 2012 Jan;129(1):48-59. doi: 10.1016/j.jaci.2011.11.006.
6
Corticosteroid-induced gene expression in allergen-challenged asthmatic subjects taking inhaled budesonide.皮质类固醇诱导吸入布地奈德的变应原激发哮喘患者的基因表达。
Br J Pharmacol. 2012 Mar;165(6):1737-1747. doi: 10.1111/j.1476-5381.2011.01620.x.
7
Expression profiling identifies Klf15 as a glucocorticoid target that regulates airway hyperresponsiveness.表达谱分析鉴定 Klf15 为糖皮质激素的靶标，调节气道高反应性。
Am J Respir Cell Mol Biol. 2011 Sep;45(3):642-9. doi: 10.1165/rcmb.2010-0369OC. Epub 2011 Jan 21.
8
Airway smooth muscle as a target of glucocorticoid action in the treatment of asthma.气道平滑肌作为糖皮质激素治疗哮喘作用的靶点。
Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 3):S201-6. doi: 10.1164/ajrccm.158.supplement_2.13tac190.
9
Glucocorticoid treatment decreases muscarinic receptor expression in canine airway smooth muscle.
Am J Physiol. 1997 Apr;272(4 Pt 1):L745-51. doi: 10.1152/ajplung.1997.272.4.L745.
10
Release of granulocyte-macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone.人培养气道平滑肌细胞释放粒细胞巨噬细胞集落刺激因子：地塞米松的抑制作用。
Br J Pharmacol. 1997 Feb;120(4):545-6. doi: 10.1038/sj.bjp.0700998.
Zotero 插件